Aperçu

Résumé (français)

Veuillez noter que les résumés n'apparaissent que dans la langue de la publication et peuvent ne pas avoir de traduction.

Résumé (anglais)

We aimed to evaluate the association of exposure to lead with glycated hemoglobin (HbA1c), fasting glucose levels (FGLs), and the likelihood for dysglycemia. We accessed data from Canada Health and Measures Survey. General linear models were used to estimate the association between blood lead concentrations (BPb) and both HbA1c and FGLs, while controlling for confounders. Multivariate logistic regression was used for assessing the relation between BPb and the likelihood for dysglycemia. FGLs in participants with moderate BPb (2.5-5.0 ug/dL) were 1.03 (95 % CI 1.00-1.06) times higher compared with participants with BPb < 2.5 ug/dL. Equivalent figures for those with BPb => 5.0 ug/dL were 1.10 (95 % CI 1.01-1.20) times, relative to the lowest stratum. This association was attenuated using HbA1c to define dysglycemia. Lead exposure was associated with the likelihood for neither FGLs => 1.10 g/L nor HbA1c => 5.7 %. The association between lead exposure and dysglycemia, if any, is likely to be very modest, at least at the population level.